Evidence map›Paper›PMID 33088661›Full record

Article3 Biotech2020

Evaluation of the anticancer activity of enzymatically synthesized Baccatin III: an intermediate precursor of Taxol®.

Balendra Sah, Madhuree Kumari, Kamalraj Subban, Jayabaskaran Chelliah

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in 3 Biotech, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Research on the Medicinal Chemistry and Pharmacology ofInternational journal of molecular sciences · 2024
    Review
  2. Insights into Taxol® biosynthesis by endophytic fungi.Applied microbiology and biotechnology · 2023
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Balendra SahDepartment of Biochemistry, Indian Institute of Science, CV Raman Rd, Bangalore, 560012 India.ORCID 0000-0002-0178-5335
Madhuree KumariDepartment of Biochemistry, Indian Institute of Science, CV Raman Rd, Bangalore, 560012 India.
Kamalraj SubbanDepartment of Biochemistry, Indian Institute of Science, CV Raman Rd, Bangalore, 560012 India.
Jayabaskaran ChelliahDepartment of Biochemistry, Indian Institute of Science, CV Raman Rd, Bangalore, 560012 India.
Indian Institute of Science Bangalore · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Baccatin III is an important precursor for the synthesis of clinically important anticancer drug Taxol. Previously, we have characterized a key enzyme of 10-deacetylbaccatin III-10-β-

Indexed as

10-Deacetylbaccatin III-10-β-O-acetyltransferase (DBAT)Apoptotic activityBaccatin IIICytotoxicPaclitaxel

Identifiers

PMID33088661
PMCPMC7544785
OpenAlexW3092579094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.